Correlation Between Pluri and BioLineRx
Can any of the company-specific risk be diversified away by investing in both Pluri and BioLineRx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pluri and BioLineRx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pluri Inc and BioLineRx, you can compare the effects of market volatilities on Pluri and BioLineRx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pluri with a short position of BioLineRx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pluri and BioLineRx.
Diversification Opportunities for Pluri and BioLineRx
Very good diversification
The 3 months correlation between Pluri and BioLineRx is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Pluri Inc and BioLineRx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioLineRx and Pluri is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pluri Inc are associated (or correlated) with BioLineRx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioLineRx has no effect on the direction of Pluri i.e., Pluri and BioLineRx go up and down completely randomly.
Pair Corralation between Pluri and BioLineRx
Given the investment horizon of 90 days Pluri is expected to generate 2.18 times less return on investment than BioLineRx. But when comparing it to its historical volatility, Pluri Inc is 1.45 times less risky than BioLineRx. It trades about 0.05 of its potential returns per unit of risk. BioLineRx is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 344.00 in BioLineRx on May 2, 2025 and sell it today you would earn a total of 57.00 from holding BioLineRx or generate 16.57% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Pluri Inc vs. BioLineRx
Performance |
Timeline |
Pluri Inc |
BioLineRx |
Pluri and BioLineRx Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pluri and BioLineRx
The main advantage of trading using opposite Pluri and BioLineRx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pluri position performs unexpectedly, BioLineRx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioLineRx will offset losses from the drop in BioLineRx's long position.Pluri vs. Can Fite Biopharma | Pluri vs. Compugen | Pluri vs. Collplant Biotechnologies | Pluri vs. Coeptis Therapeutics |
BioLineRx vs. Protalix Biotherapeutics | BioLineRx vs. Corvus Pharmaceuticals | BioLineRx vs. Aldeyra | BioLineRx vs. Can Fite Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |